Calcineurin inhibitors (tacrolimus) and steroids continue to be an important component of hepatocyte transplantation protocols, despite reports of hepatotoxicity and inhibitory effects of steroids on cell proliferation. The aim of the study was to investigate whether isolated human hepatocytes were more vulnerable to the toxicity of these agents and also to investigate their effects on hepatocyte VEGF secretion, a vascular permeability factor suggested to be involved in the cell engraftment process. Human hepatocytes were isolated from donor livers/segments rejected or unused for orthotopic liver transplantation using a collagenase perfusion technique. Hepatocytes were plated for cell function tests and to determine VEGF production. Tacrolimus (0-50 ng/ml) and methylprednisolone (0-500 ng/ml) were added to the culture media and cells incubated for 24 h. Cell metabolic activity was assessed using the MTT assay, cell number using the SRB assay, and cell attachment from hepatocyte total protein content and protein synthesis using [ 14 C]leucine incorporation. VEGF in culture supernatants was measured by ELISA. Tacrolimus and methylprednisolone had no statistically significant inhibitory effects on metabolic activity or protein synthesis compared to controls at all concentrations of the agents tested when added after plating. There were also no significant effects on cell attachment when tacrolimus or methylprednisolone was added at the time of cell plating. There were no differences in the responses obtained when either fresh or cryopreserved hepatocytes were used. The amount of VEGF secreted by untreated hepatocytes was highly variable (0-1400 pg/10 6 cells/24 h). VEGF levels in the culture supernatant from hepatocytes isolated from ≤20-year-old donors (687 ± 59 pg/10 6 cells/24 h) was significantly greater than from older donors (61 ± 7 pg/10 6 cells/24 h; p = 0.003). Tacrolimus and methylprednisolone did not significantly affect VEGF secretion by hepatocytes. Tacrolimus and methylprednisolone did not have detrimental effects on the metabolic function of human hepatocytes, cell attachment, or VEGF secretion after cell isolation. 777 778 SERRANO ET AL.
INTRODUCTION
immunosuppressive regimens are used for hepatocyte transplantation (1, 3, 5, 8, 13, 16, 29) . The immunosuppressive agents can have cytotoxic Hepatocyte transplantation is being increasingly used as a technique for bridging patients to whole-organ effects in the liver, which has been shown in rats (27) and also with rat hepatocytes (7) , but there are little data transplantation, providing metabolic support during liver failure, and replacing whole-organ transplantation in with human hepatocytes. Tacrolimus (FK-506) has been described as both a cytotoxic and cytoprotective mole-certain metabolic liver diseases. Isolated hepatocytes obtained from unused donor livers are infused into the por-cule and is associated with development of vascular injury as a result of endothelial cell toxicity. On the other tal vein or the spleen, in order to replace the deficient liver function(s). As with whole-organ transplantation, hand, tacrolimus protects rat hepatocytes against hypoxic injury by preventing mitochondrial dysfunction immunosuppressive agents are required for allogenic hepatocyte transplantation. Although some experiments (14) and also prevents Fas-induced apoptosis in human hepatocytes (10). Corticosteroids are also currently used have demonstrated less of an immune response against isolated hepatocytes than in liver transplantation, similar for immunosuppression in hepatocyte transplantation.
Methylprednisolone has inhibitory effects on liver re-East Sussex, UK). The digested tissue was minced in ice-cold EMEM containing 2% human serum albumin generation in rats after partial hepatectomy (15), which has implications for hepatocyte repopulation after hepa-(HAS) and filtered through sterile gauze. Hepatocytes were purified by washing two times with ice-cold tocyte transplantation, whereas cyclosporin A and tacrolimus may both increase hepatocyte proliferation (9) .
EMEM and 2% HAS and once with ice-cold M199/ HEPES containing 4% HAS using low-speed centrifuga-On infusion into the portal circulation transplanted cells need to become lodged in the hepatic microvascu-tion (55 × g, 5 min at 4°C). Cell yield and viability were determined using a hemocytometer and the trypan blue lature, enter the liver sinusoids, and then integrate into the hepatic parenchyma. In this process hepatocytes will exclusion technique. In some cases cells were immediately cryopreserved in UW solution containing 10% embolize the portal bed, producing microcirculatory perturbations, portal hypertension, and ischemia-reperfu-DMSO using a controlled-rate freezer (30) . sion injury. These events to a certain extent help increase endothelial permeability and disruption required Culture of Hepatocytes for transplanted cells to enter into the liver plate, but if Freshly isolated or thawed hepatocytes were plated in too many cells are infused this could be deleterious (11) .
96-well collagen-coated plates (50,000 cells/well) for One of the endogenous factors that may be released and the cell metabolic function assays and in six-well plates contribute to these events is vascular endothelial growth (2-3 × 10 6 cells/well) for VEGF production. The stanfactor (VEGF). This mediator increases vascular permedard culture conditions consisted of Williams' E meability and communicates between hepatocytes and sidium (WEM) containing 10% fetal calf serum (FCS), nusoidal endothelial cells (12). Under hypoxic condipenicillin (50 U/ml) and streptomycin (50 µg/ml), and tions VEGF receptors on endothelial cells are upregulated L-glutamine (2 mM). Cultured hepatocytes were main-(6). Hepatic sinusoidal dilatation will increase the entry tained at 37°C in 95% O 2 and 5% CO 2 . of transplanted cells into the liver plate, improving cell engraftment and decreasing microcirculatory perturba-Immunosuppressive Agents tion (26). Recent work has demonstrated that VEGF increases survival of transplanted hepatocytes within the Tacrolimus and methylprednisolone were obtained hepatic portal radicles (24) . Modulation of VEGF profrom Sigma-Aldrich (Dorset, UK). Concentrations of the duction could therefore influence the cell engraftment agents used were based on levels targeted in clinical process and repopulation of the recipient liver. Corticopractice: 10, 20, 30, 40, and 50 ng/ml in tacrolimus exsteroids have been shown to have inhibitory effects on periments and 100, 200, 300, 400, and 500 ng/ml in VEGF gene expression in human vascular smooth musmethylprednisolone experiments. Two sets of expericle cells in vitro (20). Similar effects on hepatocytes ments were performed: 1) to study the effect of immunocould be relevant to hepatocyte transplantation. The efsuppressive agents on hepatocyte function, tacrolimus fect of tacrolimus on VEGF production by cells is not and methylprednisolone were added 24 h after plating known.
to preattached cells; 2) to study the effect on cell attach-The aim of the study was to investigate whether the ment, agents were added at the same time as the hepatoimmunosuppressive drugs (tacrolimus and methylpredcytes were plated. nisolone) have effects on metabolic activity, cell attachment, and VEGF secretion of human hepatocytes in vitro.
MTT Assay MATERIALS AND METHODS
The method of Oka et al. (21) was used with some Preparation of Isolated Human Hepatocytes modifications (18) , which measures the metabolism of 3-(4,5-dimethylthiazol-2-yl)-2,5-biphenyl tetrazolium bro-Human liver tissue was obtained from 13 donor livers (8 male, 5 female) rejected or unused for orthotopic liver mide to an insoluble formazan by mitochondrial dehydrogenases only present in viable cells. Briefly, the cul-transplantation at King's College Hospital, London. The mean donor age was 30.2 ± 21.4 (SD) years. ture medium was removed by aspiration and replaced with 100 µl of fresh medium. Then 20 µl of MTT solu-Cells were isolated using a collagenase perfusion technique according to Strom et al. (28) with some mod-tion was added per well. The plates were incubated at 37°C for 4 h. The medium was then removed by aspira-ifications (17). Briefly, tissues were perfused at 37°C with buffer solutions: Hanks's balanced salt solution tion and 20 µl of trypsin was added to each well to detach the cells. Then 100 µl of isopropanolol/HCl was (HBSS, Bio Whittaker UK, Berkshire, UK) containing 0.5 mM EGTA, then HBSS and finally Eagle's modified added per well and the plate was shaken for 30 min. The OD was immediately measured at 630 nm using a Dy-essential medium (EMEM) (Cambrex UK) containing collagenase P at 500 mg/L (Roche Diagnostics Ltd., nex MRX Microplate Reader.
Sulphorhodamine B (SRB) Assay cant at a value of p < 0.05. Results are presented as mean ± SE. This assay was carried out according to Mitry et al. (19) and was used as a colorimetric measure of cell RESULTS number. After 24 h of culture, the hepatocytes were
The viability of fresh hepatocytes was 72.2 ± 3.1% washed with ice-cold PBS and 200 µl of fresh culture (n = 9) and 51.6 ± 1.9% (n = 6) in thawed cells. None medium was added to each well and 50 µl ice-cold 50% of the hepatocyte function assays were significantly altrichloroacetic acid solution was layered on top. After 1 tered by the addition of up to 50 ng/ml tacrolimus and h at 4°C to fix the cells, the wells were rinsed five times 500 ng/ml methylprednisolone (Table 1) . Thus, MTT, with tap water. The plate was then incubated at room SRB, and protein synthesis ([ 14 C]leucine incorporation) temperature for 10 min with 100 µl 0.4% SRB solution did not show any significant changes after incubation of and then rinsed five times with 1% acetic acid. When the hepatocytes with different concentrations of agents the wells were dry 200 µl of unbuffered Tris-base solufor 24 h. Fresh and cryopreserved hepatocytes showed tion (20 mM, pH 10-10.5) was added to each well. The no difference in response to the two agents. plate was placed on a gyratory shaker for 1 h and OD
In the second set of experiments, cell attachment on read at 550 nm.
plating was also not significantly altered by the presence Cell Attachment of different concentrations of tacrolimus and methylprednisolone ( Table 1) . The attached cells, measured by The cell protein content was determined using the cell protein, were similar with tacrolimus and methylmethod of Lowry with modifications to facilitate the use prednisolone-treated hepatocytes as in untreated cells. of cultured cells in 96-well plates (30) . For the total num-The amount of VEGF secreted by the different hepaber of cells added, the plate was centrifuged at 100 × g for tocyte batches was highly variable (0-1400 pg/10 6 cells/ 15 min and the medium removed carefully and protein 24 h) and was found to be related to the age of the donor concentration determined. For attached cells, the cul- (Fig. 1) . The amount of VEGF in the hepatocyte supertured hepatocytes were washed with ice-cold PBS to renatants from donors of 20 years old or younger was 10move nonattached cells and protein concentration meafold higher than from donors older than 20 years (687 ± sured. The protein in attached cells was expressed as 59 pg/10 6 cells/24 h vs. 61 ± 7 pg/10 6 cells/24 h; p = percentage of the total cell protein added. 0.003). There were no correlations of hepatocyte VEGF [ 14 C]Leucine Incorporation secretion with other factors such as sex of donor, viability of cells, attachment, or functional tests. Baseline [ 14 C]Leucine (0.2 µCi per well; Amersham Interna-VEGF secretion was not significantly different between tional, Buckinghamshire UK) in culture medium was fresh and thawed cells (196 ± 56 pg/10 6 cells/24 h vs. added to each well of a 96-well plate containing treated 188 ± 76 pg/10 6 cells/24 h). or control hepatocytes. After 24 h the cells were har-The addition of tacrolimus at the range of concentravested and transferred onto a glass fiber filter washing tions tested did not affect VEGF levels in the hepatocyte away excess [ 14 C]leucine, using a FilterMate TM Cell Harsupernatants after 24-h incubation (Fig. 2 ). There apvester (Packard Instruments, Beaconsfield, Buckingpeared to be a tendency for VEGF production to be dehamshire, UK). The filter was left to dry thoroughly creased by increasing concentrations of methylprednisoovernight before counting the [ 14 C]leucine present on the lone, but the differences were not statistically significant filter, using a Matrix TM 9600 Direct β-Counter (Packard (Fig. 3) . Instruments).
DISCUSSION

VEGF Secretion
The results of this study showed that tacrolimus and The culture supernatant was removed from the wells methylprednisolone at the concentrations tested did not and stored at −80°C until the assays were performed. have significant effects on hepatocyte metabolic activity VEGF levels in the supernatants were measured using a or cell attachment efficiency in vitro. The latter is conquantitative sandwich ELISA detection kit, according to sidered important in the context of hepatocyte transplanthe manufacturer's instructions (Quantikine human VEGF, tation, as cells need to attach to the hepatic endothelium R&D Systems, Oxfordshire, UK). The results were exas an initial part of the engraftment process. Both agents pressed in pg VEGF per million of viable cells per 24 h studied are commonly used in liver transplantation proof incubation. tocols and have also been used in the clinical studies Statistic Analysis with hepatocyte transplantation (1, 3, 5, 8, 13, 16, 29) . This lack of effect was seen in both fresh and thawed hepato-Results were analyzed by two-way ANOVA. Differences between the group means were considered signifi-cytes, indicating that the cryopreservation and thawing process does not increase susceptibility to possible ef-hepatocyte transplantation VEGF was secreted by both native and isolated hepatocytes a few hours after the fects of the immunosuppressive drugs. This is important as cryopreserved cells are the best source for hepatocyte cells were transplanted (12). VEGF produces vascular dilatation and it is also known that hepatic sinusoidal transplantation for emergency use in hepatic failure and repeated treatment of patients with hepatocytes from the dilatation by different drugs, such as nitroglycerine, increases the entry of transplanted cells into the liver sinu-same donor.
Human hepatocytes isolated from unused donor liv-soids, improves cell engraftment, and decreases microcirculatory perturbations (26). This suggests that VEGF ers preserved in UW solution secreted VEGF after the isolation process and on warm reoxygenation in culture.
could play an important role in hepatocyte engraftment after cell transplantation. The present study has shown With rat hepatocytes it was found that warm reoxygenation after cold ischemia triggered VEGF mRNA expres-that tacrolimus did not affect VEGF secretion in isolated hepatocytes during 24 h of cell culture. Tacrolimus was sion (2) . Some VEGF mRNA expression was observed after simple cold storage, whereas marked upregulation recently shown to increase VEGF expression in the kidney glomeruli of transgenic hypertensive rats, but did occurred after warm reoxygenation. In a rat model of not have effects on healthy animals (22) . Tacrolimus and islet transplantation steroid-free immunosuppression is used (25) and this may also be advantageous in hepato-cyclosporine have inhibitory effects on VEGF secretion by synovial fibroblasts from patients with rheumatoid cyte transplantation. The amount of VEGF secreted by hepatocytes was arthritis (4), but the effect of these agents on synovial cells from healthy individuals was not studied. The inhi-highly variable in the different batches of cultured cells.
Other authors have reported that a high variability in bition could be related to the presence of cellular inflammation. Most liver donors do not have fibrosis or inflam-VEGF secretion is related to specific genetic polymorphisms (32). In this study the variability appeared to be matory disease, though there may be an inflammatory response to the transplanted hepatocytes in the liver.
related to the age of the donor of the liver. Cells isolated from donors less than 20 years old had a 10-fold greater Treatment with corticosteroids decreased VEGF expression in hypertrophic chondrocytes in a rat model of VEGF production when compared to older donors. Mitry et al. found a higher viability in hepatocytes isolated chronic renal failure (23). In the present study methylprednisolone produced a slight decrease in VEGF levels, from younger donors (17) and such cells are also likely to have a greater regenerative potential (31) . These find-but this was not statistically significant. An inhibitory effect on VEGF secretion could produce detrimental ef-ings taken together would suggest that isolated hepatocytes from young donors, perhaps not surprisingly, fects on engraftment after liver cell transplantation. In 
